HYMPAVZI
Active substance: marstacimab
INJECTION, SOLUTION · MARSTACIMAB 150 mg/mL
United StatesActive
Marketing holder: Pfizer Laboratories Div Pfizer Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- MARSTACIMAB · 150 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-f579-72ac-8f4c-dcaf8bb78847,01a12091-47f1-70b3-874d-39a1a79657d6,01a12095-59e8-7bb9-9df0-9f0154ebf66a;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0069-1510
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0069-1510 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0069-1510 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0069-1510 · Verified 2026-10-09 · open in source